It sounds tempting: a payment of £3,500 to spend two weeks relaxing in front of the television, playing video games or catching up on some reading. There is a catch,

Open Orphan plc (LON:ORPH), the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine

An introduction to the facilities at hVIVO’s state of the art volunteer quarantine unit in London, plus supporting laboratory and screening facilities. https://vimeo.com/190422574 Open Orphan (LON:ORPH) was founded in 2017,

Open Orphan plc (LON:ORPH) the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine

Open Orphan Plc (LON:ORPH), the rapidly growing specialist Clinical Research Organisation pharmaceutical services company whose London-based subsidiary hVIVO is the world leader in the provision of virology and vaccine challenge study services, has today

Open Orphan plc (LON:ORPH) the rapidly growing CRO specialist pharmaceutical services Group which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study

AIM-listed Open Orphan plc (LON:ORPH) is lined up for a role in the global fight against coronavirus. Following the acquisition of hVIVO the company is a world leader in the